Disease State Maps
Structured representations of disease subtypes, mechanisms, pathways, biomarkers, and patient-relevant biology.
AI Robotix Biotech Intelligence
Building the intelligence layer for disease understanding and therapeutic discovery.
We transform complex disease biology into structured therapeutic hypotheses, testable perturbations, and AI-guided paths toward intervention.
The Approach
A control room for disease reasoning.
Each module keeps the biology, perturbation logic, modality path, and evidence trail visible in one operating view.
Therapeutic Hypothesis Engine
Templates that turn disease understanding into intervention logic: what to perturb, why it matters, and what outcome is expected.
Perturbation Reasoning
AI-assisted exploration of what to change, where to intervene, and which downstream effects may follow.
Modality Pathways
Antibodies, small molecules, RNA, protein engineering, cell-state modulation, and combination strategies.
Evidence Graph
Recommendations connect back to literature, datasets, biological assumptions, contradictions, and confidence levels.
Human Translation
A bridge from mechanism to patient-relevant validation: biomarkers, endpoints, experiments, and translational evidence.
Hypothesis to Proof
Understand -> hypothesize -> perturb -> design -> validate -> prove.
Pillar 01
Disease intelligence before drug design.
Before designing therapies, we map disease states, biological drivers, patient subtypes, and intervention opportunities. The goal is not just to find targets, but to understand where intervention could matter.
Pillar 02
From biological complexity to therapeutic hypotheses.
The platform translates disease-state understanding into structured hypotheses: what to perturb, why it matters, what result is expected, and which therapeutic modalities may be plausible.
Pillar 03
Designed for validation, not just prediction.
Each hypothesis must move toward experimental and translational proof: biomarkers, assays, model systems, patient-relevant endpoints, and evidence packages that make the next decision clearer.
“The next breakthrough will come from systems that understand disease before they design the drug.”